Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01294046 · ClinicalTrials.gov registry record · NA
Electrical Stimulation of the Sphenopalatine Ganglion for the Treatment of Migraine Headaches
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01294046 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 3 participants.
The verdict
NCT01294046, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This investigation will gather information about a procedure called sphenopalatine ganglion (SPG) stimulation, and its appropriateness, safety, and efficacy as a treatment for those who suffer migraine headaches which may result in chronic severe disability. The SPG is a small collection of nerve cells in the head, and is located near the base of the nose on either side. Participation involves the surgical implantation of an electrode (small electrical conductor) over the sphenopalatine ganglion. The electrode is connected to a stimulator which will enable treatment for migraine headaches. Tiny electrical current is delivered to the stimulator device by an internal pulse generator implanted in the area at the top of the chest, to stop the migraine headaches. The implant system will be controlled with a wireless remote provided after the implant procedure. Participation will record headache diaries throughout the study, which will last approximately 8½ months, and a yearly visit annually for five years.
Interventions
- DEVICE Deep Brain Stimulation of SPG for Migraine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2011-03 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01294046
The ClinicalTrials.gov registry entry for NCT01294046 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Deep Brain Stimulation of SPG for Migraine is the first listed.
NCT01294046 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01294046 about?
NCT01294046 is a clinical study titled "Electrical Stimulation of the Sphenopalatine Ganglion for the Treatment of Migraine Headaches". This investigation will gather information about a procedure called sphenopalatine ganglion (SPG) stimulation, and its appropriateness, safety, and efficacy as a treatment for those who suffer migraine headaches which may result in chronic severe disability. The SPG is a small collection of nerve ce...
What is the current status of trial NCT01294046?
This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2011-03. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01294046?
The interventions under investigation include: Deep Brain Stimulation of SPG for Migraine (DEVICE).
Who is sponsoring clinical trial NCT01294046?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.